Sustainability Report

Overview

The report is Ildong Pharmaceutical's first sustainability report, covering 2023 performance and selected 2024 content. It presents a double materiality assessment, TCFD-based climate strategy, and a 2050 Net Zero pathway with a 20% Scope 1 and 2 reduction target by 2030. The report discloses 2023 emissions of 2,404.68 tCO2eq for Scope 1 and 11,877.31 tCO2eq for Scope 2, alongside a workforce of 1,014 employees and 32.5% women. Independent assurance was provided by Korea Productivity Center Quality Assurance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 1 June 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview